ARDX
ARDELYX, INC.
NASDAQ · Healthcare · Biotechnology · US
$3.29
+8.58%Leverage
- Debt / equity
- 1.56x
- Net debt / equity
- 1.28x
- Debt / assets
- 0.44x
- Debt / EBITDA
- -8.93x
- Net debt / EBITDA
- -7.32x
Liquidity & coverage
- Current ratio
- 3.45x
- Quick ratio
- 3.26x
- Cash ratio
- 2.23x
- Interest coverage
- -2.66x
- EBITDA / interest
- -2.11x
- Working capital
- $313.6M
Cash & dividend
- FCF / debt
- -0.06x
- Cash flow / debt
- -0.06x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026